@crusader76 Glad to hear about the outcome of your treatment. I just finished IMRT for a local recurrence (no evidence of mets on PSMA PET scan). My PSA was only 0.11 (had been undetectable for ten years following RARP), but I also have a palpable nodule in the prostate bed that lit up on the PET scan. I declined ADT because I concluded that the benefits did not outweigh the risks in my case. I saw two oncologists (one and RO the other a MO) who were both very pro ADT but they didn’t provide convincing evidence that ADT would provide substantial benefit. I went with a third RO who was more agnostic on adding ADT, and who respected the research I did and conclusion I reached. My PCP has also been in my camp and he has been a great sounding board for me, providing critical feedback on my literature review and thinking about the risks vs benefits of ADT. Clearly, not a straightforward decision, but with my particular recurrence, I have felt equal concern for over treatment as well as under treatment. If things take a turn for the worse down the line, I will completely re-evaluate, but I am encouraged by your experience and remain optimistic for a good outcome from the IMRT alone. Best wishes for continued good numbers.